KIORA PHARMACEUTICALS INC (KPRX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, KIORA PHARMACEUTICALS INC reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $24.25M in total assets against $8.13M in total liabilities.
Key ratios (FY2025)
-67.2%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $16.02M | $0 | — | — | — | — | $1.65M | $407.5K | — |
| Operating Income | -$12.83M | $4.51M | -$12.59M | -$12.31M | -$14.24M | -$6.87M | — | -$10.84M | — | — |
| Net Income | -$10.84M | $3.59M | -$12.51M | -$13.58M | -$13.77M | -$6.86M | -$7.10M | -$10.81M | -$13.22M | — |
| EPS (Diluted) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | — | — | — | — |
| Total Assets | $24.25M | $36.48M | $13.71M | $18.68M | $20.13M | $15.30M | $10.11M | $14.28M | $14.31M | $9.73M |
| Total Liabilities | $8.13M | $10.72M | $7.60M | $7.27M | $5.55M | $5.57M | $3.49M | $5.34M | $16.23M | $10.06M |
| Shareholders' Equity | $16.13M | $25.76M | $6.11M | $11.41M | $14.58M | $9.73M | $6.62M | $8.94M | -$1.93M | -$329.4K |
| Cash & Equivalents | $8.70M | $3.79M | $2.45M | $5.96M | $7.85M | $1.19M | $3.78M | $8.00M | $7.81M | $3.64M |
| Operating Cash Flow | -$9.96M | $8.56M | -$9.56M | -$10.43M | -$10.68M | -$7.32M | -$8.15M | -$10.84M | -$6.47M | -$8.41M |
| Capital Expenditures | $110.8K | $6.3K | $0 | $0 | $63.9K | $20.1K | $0 | $20.0K | $37.0K | $0 |
| Shares Outstanding | 3.76M | 3.00M | 856.2K | 1.80M | 316.6K | 5.56M | 4.08M | 3.04M | 17.26M | 10.13M |